Menu

Recent Interviews

Ryan Jackson, CEO, Newlox Gold Ventures Corp.

Ryan Jackson
CEO | Newlox Gold Ventures Corp.
60 Laurie Crescent, V7S 1B7 West Vancouver (CAN)

info@newloxgold.com

+1 778 738 0546

Newlox CEO Ryan Jackson on building a green gold producer with a rapid growth trajectory


Nick Mather, CEO, SolGold PLC

Nick Mather
CEO | SolGold PLC
1 King Street, EC2V 8AU London (GB)

emichael@solgold.com.au

+44 20 3823 2125

SolGold CEO Nick Mather on building a major gold and copper mining company


Jared Scharf, CEO, Desert Gold Ventures Inc.

Jared Scharf
CEO | Desert Gold Ventures Inc.
4770 72nd St,, V4K 3N3 Delta (CAN)

jared.scharf@desertgold.ca

Desert Gold Ventures CEO Jared Scharf on West Africa and its potential


16. April 2020 | 07:55 CET

Johnson & Johnson, Memphasys, Procter & Gamble - for a better life

  • Health

Good health is a valuable possession. Small and large companies around the globe are engaged in research and development to make people's lives easier or better through modern and innovative products and solutions. The consumer goods and pharmaceutical sectors often offer attractive opportunities for investors to generate a lucrative return. Well-known companies with established brands usually ensure lasting sales. However, promising young companies also use innovations to attract the attention of investors and customers.

time to read: 1 minutes by Mario Hose


 

Author

Mario Hose

Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

About the author


Innovation helps with the desire for children

Memphasys from Australia deals with the subject of in-vitro fertilization. The target groups are couples who wish to have children but have not yet been able to achieve a successful pregnancy by natural means. The company has developed a product called FELIX, which is used in the field of bio-separation of sperm. With this innovation, the particularly promising sperm cells are separated from the seminal fluid in just a few minutes to increase the chances of a successful pregnancy. Initially, the focus is on artificial insemination of humans, but in the future animals will also be accompanied.

Alison Coutts is Executive Chairman of Memphasys and explains the product and future areas of application in a video - youtu.be/kHA-UhbeZH8. FELIX is expected to be launched in the second half of 2020. The company currently has a market capitalization of around AUD 35 million and a successful market launch offers corresponding potential for the shares.

Group with brands

Johnson & Johnson is a broad-based group from the USA and is a member of the Dow Jones Index. The market value of the company is around USD 390 billion. Johnson & Johnson products are available under various brands worldwide and can be found in virtually every household. The pharmaceutical and consumer goods manufacturer has a highly diversified product universe and can therefore benefit from a variety of revenue streams. Optimal conditions for conservative investors.

Dividend stock with consumer goods

Procter & Gamble is also a member of the Dow Jones Index and has a market capitalization of approximately USD 300 billion. The manufacturer of consumer goods can also offer a wide range of products from around the world on the shelves of drugstores and supermarkets. The company aims to improve the lives of its customers with products in the Care, Hygiene, Healthcare and Household segments. Due to the size of the company and the diversity of its product range, the dividend stock can build on numerous revenue streams and drive development.


Author

Mario Hose

Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

29. September 2020 | 10:51 CET | by Mario Hose

BioNTech, Bayer, Valeo Pharma: Share price jump ahead of quarterly results

  • Health

Investors' expectations of developments can drive the share price. When it comes to solving a problem or creating needs, the interest of the capital market is particularly high. Things get exciting for investors when the business model offers the possibilities of scalability. Attractive investment opportunities can be created in the fields of health and medicine, which offer extraordinary return opportunities.

Read

29. July 2020 | 07:29 CET | by Mario Hose

BioNTech, Eastman Kodak, EXMceuticals - investors have the chance to profit

  • Health

The importance of health has not been as clear for a long time as it was in 2020. Detached from the discussion about the specifics of COVID-19 on mortality compared to other viruses, the need for protection is great and helplessness without a medical response is harmful to the common good. For this reason, experts around the globe are working to find active ingredients and reduce dependence on China for care. Investors have the opportunity to profit from this development.

Read

08. June 2020 | 11:30 CET | by Mario Hose

Aurora, Bayer, XPhyto - scalable growth markets with potential

  • Health

Health is the most precious good in the life of a human being. The preservation and improvement of the quality of life is a large business area. Investors around the globe have the opportunity to participate in many different areas of research and development of products and therapies. The development of new markets and preparations usually requires a lot of risk capital before the fruits can be harvested. At the latest when a scalable solution has been found to improve people's lives, then the value of the company increases.

Read